Good morning Christos,
NU-9 is now known as AKV9. Last summer, the FDA approved AKAVA Therapeutics’ investigational new drug application, giving them the green light to begin phase 1 first-in-human testing of AKV9. To learn more about AKV9, go to https://akavatx.com/.